Relavo
PrivateLast Round
Seed
May 1, 2024
Total Funding Raised
$2.54M
Company Overview
Relavo is a medical device company developing the PeritoneX, a device that disinfects dialysis tubes to reduce the risk of infection for patients undergoing at-home peritoneal dialysis.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Telemedicine
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Relavo Comparables
Compare Relavo with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PuraCath Medical | 83% | |
| Peripal AG | 80% | |
| PeriShield | 70% |
Relavo Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 1, 2024 | ||||
| Grant | Apr 26, 2022 | ||||
| Pre Seed | Aug 26, 2020 | ||||
| Grant | Aug 3, 2020 |
Relavo Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Citrine Angels | Seed |
| FastForward U | Pre Seed |
| New York Ventures | Seed |
| San Diego Angel Conference | Seed |
| National Kidney Foundation | Seed |
| National Science Foundation | Grant |
Relavo Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Relavo's valuation, stock price, and market status.
Is Relavo a public or private company?
Relavo is a private company.
What is the current stock price of Relavo?
Relavo is a private company with no public stock price. No recent secondary market data is available.
How much is Relavo worth (valuation)?
Valuation information for Relavo is not publicly available.
Can I buy Relavo stock?
Relavo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Relavo's last funding round?
Relavo's most recent funding round was Seed on May 1, 2024.
Who are the main investors in Relavo?
Key investors in Relavo include Citrine Angels, FastForward U, New York Ventures, San Diego Angel Conference, National Kidney Foundation.
Will Relavo IPO soon?
No public IPO plans have been announced for Relavo.
How can I track Relavo secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Relavo's secondary market activity and sign up for updates.